Buy Stocks Easy | About Us
April 11, 2021
Buy Stocks Easy | Online Stocks

AVDL


Buy Avadel Pharmaceuticals plc Stock (symbol: AVDL) Easy Online

Company Name: Avadel Pharmaceuticals plc

Symbol: AVDL

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2000

AVDL Current Share Price

Today's AVDL ( Avadel Pharmaceuticals plc ) opening price: $6.2500

Yesterday's AVDL ( Avadel Pharmaceuticals plc ) closing price: $6.2900

Avadel Pharmaceuticals plc Stock ( symbol: AVDL ) Price Chart since IPO (2000):

12 Months Avadel Pharmaceuticals plc Stock ( symbol: AVDL ) Price Chart

Popular Questions about Avadel Pharmaceuticals plc Public Stock ( AVDL )

A: Avadel Pharmaceuticals plc stock symbol (also called stock or share ticker) is AVDL

A: Avadel Pharmaceuticals plc IPO (Initial Public Offering) took place on 2000

A: Avadel Pharmaceuticals plc's stock (AVDL symbol) price at ther IPO (initial Public Offering) was $6.2500

Q: Is AVDL stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Avadel Pharmaceuticals plc stock (symbol: AVDL) at the beginning of 2019, at the opening share price of $2.7800, with a minimum of $200, by now your shares would be worth $14588 and your profit would be $14388 - SHOW ONLY IF PROFIT.

Buy Avadel Pharmaceuticals plc Stock Easy Online

Avadel Pharmaceuticals plc Stock Ticker Price Chart since IPO:





Avadel Pharmaceuticals plc Stock Price Yesterday



 


Avadel Pharmaceuticals plc Stock Price – Last Week




 


Avadel Pharmaceuticals plc Stock Price – Last Month




 


Avadel Pharmaceuticals plc Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/17/1961513/0/en/Avadel-Pharmaceuticals-Completes-Enrollment-in-the-REST-ON-Phase-3-Pivotal-Trial-of-FT218-for-Excessive-Daytime-Sleepiness-and-Cataplexy-in-Patients-with-Narcolepsy.html
                            

                                
Avadel Pharmaceuticals Completes Enrollment in the REST-ON Phase 3 Pivotal Trial of FT218 for Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

                                
                                
- - -  A total of 212 patients enrolled in the REST-ON study exceed...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/16/1960902/0/en/Avadel-Pharmaceuticals-Receives-U-S-FDA-Approval-for-Nouress-AV001-a-Cysteine-Hydrochloride-Injection-for-Treating-Neonate-Patients-Requiring-Total-Parental-Nutrition-TPN.html
                            

                                
Avadel Pharmaceuticals Receives U.S. FDA Approval for Nouress™ (AV001), a Cysteine Hydrochloride Injection for Treating Neonate Patients Requiring Total Parental Nutrition (TPN)

                                
                                
USPTO issues Orange Book-listed patent for Nouress USPTO issues Ora...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/10/1958488/0/en/Avadel-Pharmaceuticals-Appoints-Dr-Mark-McCamish-to-its-Board-of-Directors.html
                            

                                
Avadel Pharmaceuticals Appoints Dr. Mark McCamish to its Board of Directors

                                
                                
DUBLIN, Ireland, Dec.  10, 2019  (GLOBE NEWSWIRE) -- Avadel Pharmac...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/commentary/662053/top-ranked-momentum-stocks-to-buy-for-december-9th
                            

                                
Top Ranked Momentum Stocks to Buy for December 9th

                                
                                
Top Ranked Momentum Stocks to Buy for December 9th


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/02/1954700/0/en/Avadel-Pharmaceuticals-Announces-Key-Appointments-to-Leadership-Team-To-Support-Continued-Transformation-and-the-Advancement-of-FT218.html
                            

                                
Avadel Pharmaceuticals Announces Key Appointments to Leadership Team To Support Continued Transformation and the Advancement of FT218

                                
                                
- - -  Thomas S. McHugh appointed as Chief Financial Officer  - - -...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/11/29/major-biopharma-catalysts-on-the-december-fda-calendar/
                            

                                
Major Biopharma Catalysts on the December FDA Calendar

                                
                                
Companies in the biotech and pharmaceutical industries are subject ...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/642919/will-avadel-pharmaceuticals-continue-to-surge-higher
                            

                                
Will Avadel Pharmaceuticals Continue to Surge Higher?

                                
                                
As of late, it has definitely been a great time to be an investor i...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/25/1951917/0/en/Avadel-Pharmaceuticals-Achieves-Enrollment-Target-in-REST-ON-Phase-3-Pivotal-Trial-of-FT218-for-Excessive-Daytime-Sleepiness-and-Cataplexy-in-Patients-with-Narcolepsy.html
                            

                                
Avadel Pharmaceuticals Achieves Enrollment Target in REST-ON Phase 3 Pivotal Trial of FT218 for Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

                                
                                
205 patients enrolled; additional patients currently in screening w...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/17/1961513/0/en/Avadel-Pharmaceuticals-Completes-Enrollment-in-the-REST-ON-Phase-3-Pivotal-Trial-of-FT218-for-Excessive-Daytime-Sleepiness-and-Cataplexy-in-Patients-with-Narcolepsy.html
                            

                                
Avadel Pharmaceuticals Completes Enrollment in the REST-ON Phase 3 Pivotal Trial of FT218 for Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

                                
                                
- - -  A total of 212 patients enrolled in the REST-ON study exceed...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/16/1960902/0/en/Avadel-Pharmaceuticals-Receives-U-S-FDA-Approval-for-Nouress-AV001-a-Cysteine-Hydrochloride-Injection-for-Treating-Neonate-Patients-Requiring-Total-Parental-Nutrition-TPN.html
                            

                                
Avadel Pharmaceuticals Receives U.S. FDA Approval for Nouress™ (AV001), a Cysteine Hydrochloride Injection for Treating Neonate Patients Requiring Total Parental Nutrition (TPN)

                                
                                
USPTO issues Orange Book-listed patent for Nouress USPTO issues Ora...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/10/1958488/0/en/Avadel-Pharmaceuticals-Appoints-Dr-Mark-McCamish-to-its-Board-of-Directors.html
                            

                                
Avadel Pharmaceuticals Appoints Dr. Mark McCamish to its Board of Directors

                                
                                
DUBLIN, Ireland, Dec.  10, 2019  (GLOBE NEWSWIRE) -- Avadel Pharmac...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/commentary/662053/top-ranked-momentum-stocks-to-buy-for-december-9th
                            

                                
Top Ranked Momentum Stocks to Buy for December 9th

                                
                                
Top Ranked Momentum Stocks to Buy for December 9th


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/02/1954700/0/en/Avadel-Pharmaceuticals-Announces-Key-Appointments-to-Leadership-Team-To-Support-Continued-Transformation-and-the-Advancement-of-FT218.html
                            

                                
Avadel Pharmaceuticals Announces Key Appointments to Leadership Team To Support Continued Transformation and the Advancement of FT218

                                
                                
- - -  Thomas S. McHugh appointed as Chief Financial Officer  - - -...


                            

                        
                    

                


                            

                    


                        
                            https://247wallst.com/healthcare-business/2019/11/29/major-biopharma-catalysts-on-the-december-fda-calendar/
                            

                                
Major Biopharma Catalysts on the December FDA Calendar

                                
                                
Companies in the biotech and pharmaceutical industries are subject ...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/642919/will-avadel-pharmaceuticals-continue-to-surge-higher
                            

                                
Will Avadel Pharmaceuticals Continue to Surge Higher?

                                
                                
As of late, it has definitely been a great time to be an investor i...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/25/1951917/0/en/Avadel-Pharmaceuticals-Achieves-Enrollment-Target-in-REST-ON-Phase-3-Pivotal-Trial-of-FT218-for-Excessive-Daytime-Sleepiness-and-Cataplexy-in-Patients-with-Narcolepsy.html
                            

                                
Avadel Pharmaceuticals Achieves Enrollment Target in REST-ON Phase 3 Pivotal Trial of FT218 for Excessive Daytime Sleepiness and Cataplexy in Patients with Narcolepsy

                                
                                
205 patients enrolled; additional patients currently in screening w...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.